Cancer Research Technology
Log in Register
Menu

Anti-CD55 [BU84]

Invented by Dr Margaret Goodall at University Of Birmingham

Info

Catalogue Number 153228
Applications IHC
Antigen/Gene or Protein Targets CD97 Ligand
Synonyms Complement decay-accelerating factor 55; Dcay accelerating factor for complement; DAF
Reactivity Human
Relevance CD55 regulates the complement system on the cell surface. It recognizes C4b and C3b fragments that are created during classical complement pathway and alternative complement pathway activation and indirectly blocks the formation of the membrane attack complex.

CD97 is a member of the epidermal growth factor-seven transmembrane family. It affects tumour aggressiveness by binding its cellular ligand CD55 and exhibits adhesive properties. Previous studies have shown that CD97 and CD55 are involved in the dedifferentiation, migration, invasiveness and metastasis of tumours.
Host Mouse
Immunogen Pre-B cells
Subclass IgG2a
Strain Balb/c
Research Area Adhesion, Cancer, Cell Type or Organelle Marker, Immunology

References

There are 5 reference entries for this reagent.

View All References

References: 5 entries

Leucocyte Typing VI, (1998): edited by T. Kishimoto, Garland Publishing, New York.

Ling et al. 1998. Clin Exp Immunol. 113(3):360-6. PMID: 9737663.

Origin and properties of soluble CD21 (CR2) in human blood.

Europe PMC ID: 9737663

Buescher et al. 1991. Public Health Rep. 106(3):333-8. PMID: 1905057.

Problems in estimating the number of women in need of subsidized prenatal care.

Europe PMC ID: 1905057


Add a reference

References: 5 entries

Leucocyte Typing VI, (1998): edited by T. Kishimoto, Garland Publishing, New York.

Ling et al. 1998. Clin Exp Immunol. 113(3):360-6. PMID: 9737663.

Origin and properties of soluble CD21 (CR2) in human blood.

Buescher et al. 1991. Public Health Rep. 106(3):333-8. PMID: 1905057.

Problems in estimating the number of women in need of subsidized prenatal care.


Add a reference